Symptoms, Subtypes, and the Biology of Classic CAH
At a Glance
Classic congenital adrenal hyperplasia (CAH) has two main subtypes: salt-wasting and simple-virilizing. Both involve low cortisol and high androgens, requiring lifelong hormone replacement. Salt-wasting CAH is more severe, carrying a risk of life-threatening dehydration and shock.
While both are considered “classic” forms of Congenital Adrenal Hyperplasia (CAH), the salt-wasting and simple-virilizing subtypes differ in how much of the vital 21-hydroxylase enzyme is missing. Understanding the biology of these subtypes can help you recognize why your baby’s treatment and monitoring are so critical [1][2].
The Adrenal Chain Reaction
In a healthy body, the pituitary gland (in the brain) acts like a thermostat, monitoring cortisol levels. When cortisol is low, the pituitary releases a hormone called ACTH (adrenocorticotropic hormone) to tell the adrenal glands to make more [3][4].
In classic CAH, the 21-hydroxylase enzyme “worker” is mostly or completely missing. This creates a dangerous loop:
- Low Cortisol: The adrenal glands cannot finish making cortisol [1].
- ACTH Overdrive: The brain senses the low cortisol and floods the body with ACTH, trying to force the adrenal glands to work harder [3][5].
- Adrenal Hyperplasia: This constant “shouting” from the ACTH causes the adrenal glands to grow larger (hyperplasia) [3][5].
- Androgen Excess: Because the normal path to cortisol is blocked, the glands are forced to use the “back-up” path, creating a massive oversupply of androgens (male-type hormones) [6][7].
Subtype 1: Salt-Wasting CAH
This is the most severe form of classic CAH, occurring when the 21-hydroxylase enzyme is almost entirely absent.
- The Biological Gap: In addition to low cortisol, the body cannot produce aldosterone, the hormone that tells the kidneys to keep sodium and get rid of potassium [1][8].
- The Risk: Without aldosterone, the baby “wastes” salt in their urine. This can lead to a salt-wasting crisis, a life-threatening emergency characterized by severe dehydration, dangerous electrolyte imbalances, and low blood pressure (shock) [9][10].
- Signs to Watch For: In newborns, signs of an impending crisis include poor feeding, vomiting, weight loss, and extreme lethargy [11][9].
Subtype 2: Simple-Virilizing CAH
In this “classic” form, there is just enough enzyme activity (usually about 1-2%) to produce a small amount of aldosterone, which prevents salt-wasting [1][12].
- The Biological Gap: While salt levels remain stable, the body still cannot make enough cortisol, and the androgen overproduction remains high [1][2].
- Symptoms of Androgen Excess: The most common sign in female newborns is virilization (masculinization of the external genitalia). In both boys and girls, high androgens can later lead to rapid growth followed by early puberty and short adult stature [13][14].
Comparison of Classic Subtypes
| Feature | Salt-Wasting (Classic) | Simple-Virilizing (Classic) |
|---|---|---|
| Enzyme Activity | Nearly 0% [1] | Roughly 1–2% [1] |
| Aldosterone | Severely deficient [8] | Sufficient to maintain salt [1] |
| Key Risk | Life-threatening dehydration [9] | Virilization/Rapid growth [13] |
| Newborn Signs | Vomiting, lethargy, low sodium [9] | Ambiguous genitalia in females [14] |
Regardless of the subtype, both require lifelong hormone replacement therapy to keep the body in balance and prevent complications [15][16]. Early diagnosis through screening is a vital tool that prevents the most dangerous outcomes of salt-wasting [17][18].
For more details on the testing process, see Testing and Diagnosis: From Screening to Certainty.
Common questions in this guide
What is the difference between salt-wasting and simple-virilizing CAH?
What are the signs of a salt-wasting crisis in a newborn?
Why does CAH cause high androgen levels?
Will my baby need lifelong treatment for classic CAH?
What is a stress dosing protocol for CAH?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Does my baby have enough aldosterone to maintain their salt and water balance, or will they need mineralocorticoid supplements?
- 2.What were the results of the electrolyte panel? Specifically, what are my baby's sodium and potassium levels?
- 3.Since my son doesn't have outward physical signs like virilization, what are the subtle symptoms of high androgens we should look for as he grows?
- 4.How often will we need to test my baby's hormone levels to ensure their ACTH is being properly suppressed?
- 5.What is the 'stress dosing' protocol we should follow if our baby gets a fever or becomes ill?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (18)
- 1
Genetic characterization of a large cohort of Argentine 21-hydroxylase Deficiency.
Fernández CS, Taboas M, Bruque CD, et al.
Clinical endocrinology 2020; (93(1)):19-27 doi:10.1111/cen.14190.
PMID: 32289882 - 2
Steroid 21-hydroxylase deficiency in congenital adrenal hyperplasia.
Parsa AA, New MI
The Journal of steroid biochemistry and molecular biology 2017; (165(Pt A)):2-11 doi:10.1016/j.jsbmb.2016.06.015.
PMID: 27380651 - 3
MECHANISMS IN ENDOCRINOLOGY: Rare defects in adrenal steroidogenesis.
Miller WL
European journal of endocrinology 2018; (179(3)):R125-R141.
PMID: 29880708 - 4
Assessment of medication adherence in children and adults with congenital adrenal hyperplasia and the impact of knowledge and self-management.
Ekbom K, Strandqvist A, Lajic S, et al.
Clinical endocrinology 2021; (94(5)):753-764 doi:10.1111/cen.14398.
PMID: 33346381 - 5
Management challenges and therapeutic advances in congenital adrenal hyperplasia.
Mallappa A, Merke DP
Nature reviews. Endocrinology 2022; (18(6)):337-352 doi:10.1038/s41574-022-00655-w.
PMID: 35411073 - 6
Clinical Manifestations and Treatment Challenges in Infants and Children With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.
Nokoff NJ, Buchanan C, Barker JM
The Journal of clinical endocrinology and metabolism 2025; (110(Supplement_1)):S13-S24 doi:10.1210/clinem/dgae563.
PMID: 39836622 - 7
Non-classical congenital adrenal hyperplasia: current insights into clinical implications, diagnosis and treatment.
Loli P, Menotti S, di Filippo L, Giustina A
Endocrine 2025; (90(1)):1-16 doi:10.1007/s12020-025-04341-5.
PMID: 40699527 - 8
Update on adrenal steroid hormone biosynthesis and clinical implications.
Bacila IA, Elder C, Krone N
Archives of disease in childhood 2019; (104(12)):1223-1228 doi:10.1136/archdischild-2017-313873.
PMID: 31175123 - 9
A Neonate Presenting with Severe Dehydration: A Rare Case of Congenital Adrenal Hyperplasia with Salt Losing Crisis.
Lamichhane A, Phuyel R, Upreti M, Khadka R
JNMA; journal of the Nepal Medical Association 2024; (62(278)):706-708 doi:10.31729/jnma.8777.
PMID: 40655893 - 10
The presentation of congenital adrenal hyperplasia in an unscreened population.
Conlon TA, Hawkes CP, Brady JJ, Murphy NP
Journal of pediatric endocrinology & metabolism : JPEM 2021; (34(9)):1123-1129 doi:10.1515/jpem-2021-0123.
PMID: 34167176 - 11
Nonvirilized Genitalia in 3 Female Newborns With the Salt-Wasting Congenital Adrenal Hyperplasia Phenotype.
Yauch L, Mayhew A, Gomez-Lobo V, et al.
Journal of the Endocrine Society 2021; (5(1)):bvaa169 doi:10.1210/jendso/bvaa169.
PMID: 33294764 - 12
Clinical Role of CYP2C19 Polymorphisms in Patients with Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency.
Grošelj U, Žerjav Tanšek M, Trebušak Podkrajšek K, et al.
Acta chimica Slovenica 2016; (63(1)):33-7 doi:10.17344/acsi.2015.1797.
PMID: 26970786 - 13
Antenatal Diagnosis and Treatment in Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency and Congenital Adrenal Hyperplasia Screening in Newborns
Yavaş Abalı Z, Kurnaz E, Güran T
Journal of clinical research in pediatric endocrinology 2025; (17(Suppl 1)):33-43 doi:10.4274/jcrpe.galenos.2024.2024-6-10-S.
PMID: 39713885 - 14
Absence of uterus and presence of verumontanum in a 46 XX patient with Congenital adrenal hyperplasia reared as male: A case report with literature review.
Bapir R, Aghaways I, Ahmed SF, et al.
Urology case reports 2025; (60()):103028 doi:10.1016/j.eucr.2025.103028.
PMID: 40236908 - 15
Management of Infants with Congenital Adrenal Hyperplasia.
Dabas A, Vats P, Sharma R, et al.
Indian pediatrics 2020; (57(2)):159-164.
PMID: 32060243 - 16
[Long-term morbidity in congenital adrenal hyperplasia].
Tschaidse L, Quitter F, Hübner A, Reisch N
Der Internist 2022; (63(1)):43-50 doi:10.1007/s00108-021-01223-6.
PMID: 34978615 - 17
The progression of salt-wasting and the body weight change during the first 2 weeks of life in classical 21-hydroxylase deficiency patients.
Gau M, Konishi K, Takasawa K, et al.
Clinical endocrinology 2021; (94(2)):229-236 doi:10.1111/cen.14347.
PMID: 33001476 - 18
[Newborn screening for congenital hypothyroidism and congenital adrenal hyperplasia: Benefits and costs of a successful public health program].
Van Vliet G, Grosse SD
Medecine sciences : M/S 2021; (37(5)):528-534 doi:10.1051/medsci/2021053.
PMID: 34003099
This page explains the biology and subtypes of classic CAH for educational purposes. Always consult your pediatric endocrinologist for specific medical advice, treatment adjustments, and emergency protocols for your child.
Get notified when new evidence is published on Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.